ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Associate Director, Translational Medicine at Cogent Biosciences - ApplyBlast

Associate Director, Translational Medicine

Cogent Biosciences

1 month ago

3.8 on Glassdoor

Waltham, Massachusetts, United States

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Associate Director, Translational Medicine leads biomarker strategies to accelerate program transitions from discovery to clinical development at Cogent Biosciences. This role involves partnering with cross-functional teams to support patient selection, predict drug efficacy, and manage the implementation of clinical trial biomarker strategies. The position requires providing subject matter expertise and scientific leadership to drive translational medicine initiatives.

Responsibilities

Lead implementation of biomarker strategies to accelerate program transition from discovery to clinical development
Oversee use of biomarkers in clinical studies and write protocols for incorporation in clinical trials
Analyze and interpret results of clinical biomarker analyses to support regulatory filings and publications

Skills

Qualifications

PhD in BiologyPhD in PharmacologyPhD in Genetics/Genomics

About Cogent Biosciences

cogentbio.com

Headquarters

Waltham, Massachusetts, United States

Company Size

51-200 employees

Founded

2014

View Profile

Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases, including cancers, autoimmune conditions, and rare diseases. The company leverages validated biology to design best-in-class small molecule therapeutics, with its lead program bezuclastinib targeting conditions such as Systemic Mastocytosis and Gastrointestinal Stromal Tumors (GIST). Cogent operates discovery and development offices in Boulder, Colorado and Waltham, Massachusetts, and is actively advancing clinical-stage programs including a Phase 3 trial and an FDA-accepted NDA for bezuclastinib.